SCHEMBL23911682

SCHEMBL23911682

c1cc2nc(c1)-c1ccc(cc1)-c1ccc(cc1)-c1ccc(cc1)-c1ccc(cc1)-c1ccc-2cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.72
KMT2A Q03164 6/20 0.72
RAB9A P51151 4/20 0.72
ALDH1A1 P00352 5/20 0.70
MAPT P10636 4/20 0.70
HPGD P15428 3/20 0.70
HSD17B10 Q99714 2/20 0.70
POLB P06746 1/20 0.70
ASIC3 Q9UHC3 1/20 0.50
KDM4E B2RXH2 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
CCR1 P32246 2/20 0.43
CCR8 P51685 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 2/20 0.43
ALPL P05186 1/20 0.43
HSP90AA1 P07900 1/20 0.43
ALPI P09923 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911681 1.00 MEN1 (0.72) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL3631391 0.91 MEN1 (0.89) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL18732402 0.91 MEN1 (0.89) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL23921025 0.87 KMT2A (0.56) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL5950610 0.87 MAPT (0.95) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL18270323 0.84 MEN1 (0.76) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL58442 0.84 MEN1 (1.00) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL4943174 0.83 MAPT (1.00) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL4348467 0.83 RAB9A (0.59) MEN1KMT2ARAB9AALDH1A1MAPT
SCHEMBL6550571 0.83 RAB9A (0.59) MEN1KMT2ARAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11142500-B2 Nanohoop compound embodiments comprising meta-substitution and molecular systems comprising the same UNIVERSITY OF OREGON (US) 2021-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11142500-B2 Nanohoop compound embodiments comprising meta-substitution and molecular systems comprising the same MYC, KRAS, NRAS MEN1 145/4885KMT2A 2503/4885RAB9A 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.